These lab-manufactured alternatives were not formulated with leisure use in mind. In the 1990s, John W. Huffman as well as a staff of fellow chemists at Clemson University created some of the to start with formulation for synthetic cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological impacts